Minimal agreement between basophil activation test and immunoassay in diagnosis of penicillin allergy
Main Article Content
Keywords
Basophil activation test, Immunoassay, Penicillin, Allergy
Abstract
Introduction: Basophil activation test (BAT) and immunoassays are the most widely used in vitro tests to diagnose IgE-mediated allergic reactions to penicillin. However, studies to determine if one test is interdependent from another are limited.
Objective: The present study aimed to measure the agreement between BAT and immunoassay in diagnosis of penicillin allergy.
Method: BAT was performed using penicillin G (Pen G), penicillin V (Pen V), penicilloylpolylysine (PPL), minor determinant mix (MDM), amoxicillin (Amx) and ampicillin (Amp) in 25 patients. Immunoassay of total IgE (tIgE) and specific IgE (sIgE) antibodies to Pen G, Pen V, Amx and Amp were quantified. Skin prick test (SPT) using PPL-MDM, Amx, Amp and Clavulanic acid were also performed.
Results: Minimal agreement was observed between BAT and immunoassay (k = 0.25). Of two BATpositive patients, one patient is positive to Amx (59.27%, SI = 59) and Amp (82.32%, SI = 82) but sIgE-negative to all drug tested. This patient is also SPT-positive to both drugs. Another patient is BAT-positive to Pen G (10.18%, SI = 40), Pen V (25.07%, SI = 100) and Amp (19.52%, SI = 79). In sIgE immunoassay, four patients were sIgE-positive to at least one of the drugs tested. The sIgE level of three patients was between low and moderate and they were BAT-negative. One BAT-positive patient had a high level of sIgE antibodies (3.50-17.5 kU/L) along with relatively high specific to total IgE ratio ≥0.002 (0.004-0.007).
Conclusions: The agreement between BAT and immunoassay is minimal. Performing both tests provides little increase in the sensitivity of allergy diagnosis work-up for immediate reactions to penicillin.
References
2. Soria A, Autegarden E, Amsler E, Gaouar H, Vial A, Francès C, et al. A clinical decision-making algorithm for penicillin allergy. Ann Med. 2017;49:710-7.
3. Meng X, Jenkins RE, Berry NG, Maggs JL, Farrell J, Lane CS, et al. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol Exp Ther. 2011;338:841-9.
4. Torres MJ, Adkinson NF, Caubet J-C, Khan DA, Kidon MI, Mendelson L, et al. Controversies in drug allergy: betalactam hypersensitivity testing. J Allergy Clin Immunol Pract. 2019;7:40-5.
5. Torres MJ, Blanca M, Fernandez J, Romano A, de Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to betalactam antibiotics. Allergy. 2003;58:961-72.
6. Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015;70:1393-405.
7. Hamilton RG, Adkinson NF. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol. 2004;114:213-25.
8. Khan FM, Ueno-Yamanouchi A, Serushago B, Bowen T, Lyon AW, Lu C, et al. Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E. Allergy Asthma Clin Immunol. 2012;8:1.
9. Hjortlund J, Mortz CG, Stage TB, Skov PS, Dahl R, BindslevJensen C. Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance. Clin Transl Allergy. 2014;4:34.
10. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. Allergy. 1999;54:999-1003.
11. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276-82.
12. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2016;71:1103-34.
13. Mayorga C, Dona˜ I, Perez-Inestrosa E, Fernández DT, Torres JM. The value of in vitro tests to diminish drug challenges. Int J Mol Sci. 2017;18:1-20.
14. Marraccini P, Pignatti P, D’Alcamo A, Salimbeni R, Consonni D. Basophil activation test application in drug hypersensitivity diagnosis: an empirical approach. Int Arch Allergy Immunol. 2018;177:160-6.
15. Johansson SG, Adedoyin J, Van HM, Gronneberg R, Nopp A. False-positive penicillin immunoassay: an unnoticed common problem. J Allergy Clin Immunol. 2013;132:235-7.
16. Hagau˘ N, Sfichi M, Bologa R, Cocu S, Indrei C, Alb I, et al. Basophil activation test using flow cytometry in the diagnostic of antibiotic allergy. Rev Romana Med Lab. 2010;18:47-53.
17. Torres MJ, Blanca M. The complex clinical picture of betalactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am. 2010;94:805-20.
18. Fernandez TD, Torres MJ, Blanca-Lopez N, Rodriguez-Bada JL, Gomez E, Canto G, et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy. 2009;64:242-8.
19. Salas M, Fernández-Santamaría R, Mayorga C, Barrionuevo E, Ariza A, Posadas T, et al. Use of the basophil activation test may reduce the need for drug provocation in amoxicillin-alavulanic allergy. J Allergy Clin Immunol Pract. 2018;6:1010-8.
20. Vultaggio A, Virgili G, Gaeta F, Romano A, Maggi E, Matucci A. High serum -lactams specific/total IgE ratio is associated with immediate reactions to -lactams antibiotics. PLoS ONE. 2015;10:1-11.
21. Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, et al. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017;7:1-13.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.